Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Energy and Renewables
  • IT & Communications
  • Chemicals & Materials
  • Pharma & Biotech
  • Medical Equipment & Supplies

University

  • King's College London
  • Queen Mary, University of London
  • University of Bath
  • University of Bristol
  • University of Cardiff (Fusion IP)
  • University of Glasgow
  • University of Leeds
  • University of Oxford
  • University of Sheffield (Fusion IP)
  • University of Southampton
  • University of Surrey
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • Top 10 Holdings
    by value

Search keyword

Medical Equipment & Supplies

University: Leeds

Company Stage: Quoted

Website: http://www.avacta.com

Avacta Group Plc

Avacta is developing innovative chemical and biological detection technology for the healthcare, defence, biotechnology and pharmaceuticals sectors.

Avacta's market driven technology portfolio has applications in homeland security, clinical diagnostics and personalised medicine, high throughput screening and bioprocess measurement.

As at 31 Dec 2012

IP Group holding

IP Venture Fund* holding

29.8%
2.6%

*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt

Avacta

Related news

30 Apr 2013
Avacta Group plc - Interim results
27 Feb 2013
Avacta Group plc - Business update

There is currently no news available.

More portfolio news